Search in:

Advanced search

Infection and Drug Resistance Volume 10, 2017 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Incomplete recovery of the fecal flora of hematological patients with neutropenia and repeated fluoroquinolone prophylaxis

Yong Chong1 Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical SciencesCorrespondence[email protected]

Shinji Shimoda1 Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences

Noriko Miyake1 Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences

Takatoshi Aoki2 Department of Blood and Marrow Transplantation, Hara-Sanshin Hospital, Fukuoka

Yoshikiyo Ito3 Department of Internal Medicine, Kyushu University Beppu Hospital, Beppu

Tomohiko Kamimura2 Department of Blood and Marrow Transplantation, Hara-Sanshin Hospital, Fukuoka

Nobuyuki Shimono4 Center for the Study of Global Infection, Kyushu University Hospital, Fukuoka, Japan

show all

Pages 193-199 | Published online: 27 Jun 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

ViscoliCCastagnolaETreatment of febrile neutropenia: what is new?Curr Opin Infect Dis20021537738212130933
PubMed Web of Science ®Google Scholar
BucaneveGMicozziAMenichettiFLevofloxacin to prevent bacterial infection in patients with cancer and neutropeniaN Engl J Med200535397798716148283
PubMed Web of Science ®Google Scholar
Gafter-GviliAFraserAPaulMLeiboviciLMeta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patientsAnn Intern Med200514297999515968013
PubMed Web of Science ®Google Scholar
LeiboviciLPaulMCullenMAntibiotic prophylaxis in neutropenic patients: new evidence, practical decisionsCancer20061071743175116977651
PubMed Web of Science ®Google Scholar
FreifeldAGBowEJSepkowitzKAClinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of AmericaClin Infect Dis20115242743121205990
PubMed Web of Science ®Google Scholar
PascoeJStevenNAntibiotics for the prevention of febrile neutropeniaCurr Opin Hematol200916485219057204
PubMed Web of Science ®Google Scholar
CullenMBaijalSPrevention of febrile neutropenia: use of prophylactic antibioticsBr J Cancer2009101Suppl 1S11S1419756000
PubMed Web of Science ®Google Scholar
SaitoTYoshiokaSIinumaYEffects on spectrum and susceptibility patterns of isolates causing bloodstream infection by restriction of fluoroquinolone prophylaxis in a hematology-oncology unitEur J Clin Microbiol Infect Dis20082720921618058141
PubMed Web of Science ®Google Scholar
SohnBSYoonDHKimSThe role of prophylactic antimicrobials during autologous stem cell transplantation: a single-center experienceEur J Clin Microbiol Infect Dis2012311653166122138805
PubMed Web of Science ®Google Scholar
VerlindenAJansensHGoossensHClinical and microbiological impact of discontinuation of fluoroquinolone prophylaxis in patients with prolonged profound neutropeniaEur J Haematol20149330230824750350
PubMed Web of Science ®Google Scholar
ChongYShimodaSYakushijiHClinical impact of fluoroquinolone-resistant Escherichia coli in the fecal flora of hematological patients with neutropenia and levofloxacin prophylaxisPLoS One20149e8521024465506
PubMed Web of Science ®Google Scholar
National Committee for Clinical Laboratory StandardsPerformance Standards for Antimicrobial Susceptibility Testing. 14th Informational SupplementWayne, PennsylvaniaNCCLS2004
Google Scholar
de LastoursVCambauEGuillardTMarcadeGChauFFantinBDiversity of individual dynamic patterns of emergence of resistance to quinolones in Escherichia coli from the fecal flora of healthy volunteers exposed to ciprofloxacinJ Infect Dis20122061399140622930806
PubMed Web of Science ®Google Scholar
DethlefsenLRelmanDAIncomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbationProc Natl Acad Sci U S A2011108Suppl 14554456120847294
PubMed Web of Science ®Google Scholar
CarratalàJFernandez-SevillaATubauFDominguezMÁGudiolFEmergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxisAntimicrob Agents Chemother1996405035058834911
PubMed Web of Science ®Google Scholar
PereaSHidalgoMArcedianoAIncidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxisJ Antimicrob Chemother19994411712010459819
PubMed Web of Science ®Google Scholar
NgES-TLiewYEarnestAKohLPLimS-WHsuLYAudit of fluoroquinolone prophylaxis against chemotherapy-induced febrile neutropenia in a hospital with highly prevalent fluoroquinolone resistanceLeuk Lymphoma20115213113320929324
PubMed Web of Science ®Google Scholar
BowEJFluoroquinolones, antimicrobial resistance and neutropenic cancer patientsCurr Opin Infect Dis20112454555322001945
PubMed Web of Science ®Google Scholar
ChongYItoYKamimuraTGenetic evolution and clinical impact in extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniaeInfect Genet Evol2011111499150421689785
PubMed Web of Science ®Google Scholar
ChongYYakushijiHItoYKamimuraTClinical and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from JapanEur J Clin Microbiol Infect Dis201130838720859753
PubMed Web of Science ®Google Scholar
ChongYShimodaSYakushijiHCommunity spread of extended-spectrum β-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis: a long-term study in JapanJ Med Microbiol2013621038104323538565
PubMed Web of Science ®Google Scholar
ChongYYakushijiHItoYKamimuraTClinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignanciesInt J Infect Dis201115e277e28121324723
PubMed Web of Science ®Google Scholar
CraigMCumpstonADHobbsGRDevettenMPSarwariAREricsonSGThe clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unitBone Marrow Transplant20073947748217322937
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Incomplete recovery of the fecal flora of hematological patients with neutropenia and repeated fluoroquinolone prophylaxis

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Incomplete recovery of the fecal flora of hematological patients with neutropenia and repeated fluoroquinolone prophylaxis

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date